THE POTENTIAL OF PLURIPOTENT STEM CELL-BASED THERAPY AND EXTRACELLULAR VESICLES IN PROMOTING TISSUE REGENERATION
Downloads
Stem cell research has paved the way for revolutionary regenerative therapies targeting damaged and diseased tissues. Beyond traditional cell transplantation, current evidence suggests that therapeutic benefits are primarily mediated through paracrine effects. Extracellular vesicles (EVs), which can traverse biological barriers and deliver bioactive molecules, represent a promising avenue for cell-free therapy. Tissue engineering, as the second-generation regenerative innovation, integrates biodegradable 3D scaffolds with cells to mimic natural extracellular matrices, enhancing therapeutic outcomes. This study examines the potential of EVs across diverse applications. In ocular regeneration, neural progenitor-derived EVs preserve photoreceptor cells and mitigate retinal inflammation in retinitis pigmentosa. For skin repair, EVs derived from mesenchymal stem cells (MSCs) support key phases of wound healing by modulating macrophage polarization and activating molecular pathways like RAC-alpha and Notch signaling. In cardiovascular therapy, EVs contribute to heart tissue recovery, reduce myocardial apoptosis, and combat fibrosis through targeted gene modulation. Skeletal muscle regeneration benefits from EVs enhancing myogenic differentiation, decreasing fibrosis, and addressing excessive extracellular matrix accumulation common in disorders like muscular dystrophy. The ability of EVs to emulate paracrine signaling processes expands the horizons of regenerative medicine, offering a scalable and efficient alternative to cell-based therapies. Literature highlights the critical role of high-quality, large-scale production under stringent standards to ensure therapeutic consistency. These findings underscore EVs as potent, cell-free agents capable of driving tissue repair and regeneration. Further investigations are encouraged to optimize production, application, and integration with advanced biomaterials for clinical efficacy.
Bian, B., Zhao, C., He, X., Gong, Y., Ren, C., Ge, L., Zeng, Y., Li, Q., Chen, M., Weng, C., He, J., Fang, Y., Xu, H. and Yin, Z. Q. (2020), “Exosomes derived from neural progenitor cells preserve photoreceptors during retinal degeneration by inactivating microglia”, Journal of Extracellular Vesicles, Vol. 9 No. 1.
Choi, J. S., Yoon, H. I., Lee, K. S., Choi, Y. C., Yang, S. H., Kim, I. S. and Cho, Y. W. (2016), “Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and
provide biochemical cues for skeletal muscle regeneration”, Journal of Controlled Release, Vol. 222, pp. 107-15.
Chu, G. Y., Chen, Y. F., Chan, M. H., Gau, C. S. and Weng, S. M. (2018), “Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues”, Journal of Food and Drug Analysis, Vol. 26 No. 1, pp. 14-20.
da Fonseca Ferreira, A. and Gomes, D. A. (2018), “Stem Cell Extracellular Vesicles in Skin Repair”, Bioengineering, Vol. 6 No. 1, pp. 4.
de Oliveira Gonzalez, A. C., Costa, T. F., de Araújo Andrade, Z. and Medrado, A. R. A. P. (2016), “Wound healing - A literature review”, Anais Brasileiros de Dermatologia, Vol. 91 No. 5, pp. 614-20.
Fry, C. S., Kirby, T. J., Kosmac, K., McCarthy, J. J. and Peterson, C. A. (2017), “Myogenic Progenitor Cells Control Extracellular Matrix Production by Fibroblasts during Skeletal Muscle Hypertrophy”, Cell Stem Cell, Vol. 20 No. 1, pp. 56-69.
Ghareeb, A. E., Lako, M. and Steel, D. H. (2020), “Coculture techniques for modeling retinal development and disease, and enabling regenerative medicine”, Stem Cells Translational Medicine, Vol. 9 No. 12, pp. 1531-48.
Ha, D. H., Kim, H. K., Lee, J., Kwon, H. H., Park, G. H., Yang, S. H., Jung, J. Y., Choi, H., Lee, J. H., Sung, S., Yi, Y. W. and Cho, B. S. (2020), “Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration”, Cells, Vol. 9 No. 5, pp. 1157.
Hesketh, M., Sahin, K. B., West, Z. E. and Murray, R. Z. (2017), “Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing”, International Journal of Molecular Sciences, Vol. 18 No. 7, pp. 1545.
He, X., Dong, Z., Cao, Y., Wang, H., Liu, S., Liao, L., Jin, Y., Yuan, L. and Li, B. (2019), “MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing”, Stem Cells International, Vol. 2019.
Jarrige, M., Frank, E., Herardot, E., Martineau, S., Darle, A., Benabides, M., Domingues, S., Chose, O., Habeler, W., Lorant, J., Baldeschi, C., Martinat, C., Monville, C., Morizur, L. and M’Barek, K. B. (2021), “The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles”, Cells, Vol. 10 No. 2, pp. 240.
Kervadec, A., Bellamy, V., Harane, N. E., Arakélian, L., Vanneaux, V., Cacciapuoti, I., Nemetalla, H., Périer, M. C., Toeg, H. D., Richart, A., Lemitre, M., Yin, M., Loyer, X., Larghero, J., Hagège, A., Ruel, M., Boulanger, C. M., Silvestre, J. S., Menasché, P. and Renault, N. K. E. (2016), “Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure”, Journal of Heart and Lung Transplantation, Vol. 35 No. 6, pp. 795-807.
Kharraz, Y., Guerra, J., Pessina, P., Serrano, A. L. and Muñoz-Cánoves, P. (2014), “Understanding the process of fibrosis in Duchenne muscular dystrophy”, BioMed Research International, Vol. 2014.
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., oakley, R. M. E., Pasterkamps, G., de Kleijn, D. P. V., Lim, S. K. (2010), “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury”, Stem Cell Research, Vol. 4 No. 3, pp. 214-22.
Liu, L., Yu, Y., Hou, Y., Chai, J., Duan, H., Chu, W., Zhang, H., Hu, Q. and Du, J. (2014), “Human umbilical cord
mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats”, PloS One, Vol. 9 No. 2.
Liu, Y., Chen, S. J., Li, S. Y., Qu, L. H., Meng, X. H., Wang, Y., Xu, H. W., Liang, Z. Q. and Yin, Z. Q. (2017), “Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients”, Stem Cell Research & Therapy, Vol. 8 No. 1, pp. 209.
Luo, J., Baranov, P., Patel, S., Ouyang, H., Quach, J., Wu, F., Qiu, A., Luo, H., Hicks, C., Zeng, J., Zhu, J., Lu, J., Sfeir, N., Wen, C., Zhang, M., Reade, V., Patel, S., Sinden, J., Sun, X., Shaw, P., Young, M. and Zhang, K. (2014), “Human retinal progenitor cell transplantation preserves vision”, Journal of Biological Chemistry, Vol. 289 No. 10, pp. 6362-71.
M’Barek, K. B. and Monville, C. (2019), “Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering”, Stem Cells International, Vol. 2019.
Morizur, L., Herardot, E., Monville, C. and M’Barek, K. B. (2020), “Human pluripotent stem cells: A toolbox to understand and treat retinal degeneration”, Molecular and Cellular Neurosciences, Vol. 107.
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N. and Yamanaka, S. (2008), “Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts”, Nature Biotechnology, Vol. 26 No. 1, pp. 101-6.
Peng, B., Xiao, J., Wang, K., So, K., Tipoe, G. L. and Lin, B. (2014), “Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa”, Journal of Neuroscience, Vol. 34 No. 24, pp. 8139-50.
Qazi, T. H., Duda, G. N., Ort, M. J., Perka, C., Geissler, S. and Winkler, T. (2019), “Cell therapy to improve regeneration of skeletal muscle injuries”, Journal of Cachexia, Sarcopenia and Muscle, Vol. 10 No. 3, pp. 501-16.
Sun, B. K., Siprashvili, Z. and Khavari, P. A. (2014), “Advances in skin grafting and treatment of cutaneous wounds”, Science, Vol. 346 No. 6212, pp. 941-5.
Sze, S. K., de Kleijn, D. P. V., Lai, R. C., Tan, E. K. W., Zhao, H., Yeo, K. S., Low, T. Y., Lian, Q., Lee, C. N., Mitchell, W., Oakley, M. R. E. and Lim, S. K. (2007), “Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells”, Molecular & Cellular Proteomics, Vol. 6 No. 10, pp. 1680-9.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007), “Induction of pluripotent stem cells from adult human fibroblasts by defined factors”, Cell, Vol. 131 No. 5, pp. 861-72.
Ti, D., Hao, H., Tong, C., Liu, J., Dong, L., Zheng, J., Zhao, Y., Liu, H., Fu, X. and Han, W. (2015), “LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b”, Journal of Translational Medicine, Vol. 13, pp. 308.
Timmers, L., Lim, S. K., Hoefer, I. E., Arslan, F., Lai, R. C., van Oorschot, A. A. M., Goumans, M. J., Strijder, C., Sze, S. K., Choo, A., Piek, J. J., Doevendans, P. A., Pasterkamp, G. and de Kleijn, D. P. V. (2011), “Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction”, Stem Cell Research, Vol. 6 No. 3, pp. 206-14.
Wang, L., Hu, L., Zhou, X., Xiong, Z., Zhang, C., Shehada, H. M. A., Hu, B., Song, J. and Chen, L. (2017), “Exosomes secreted
by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling”, Scientific Reports, Vol. 7 No. 13321.
Wang, S., Girman, S., Lu, B., Bischoff, N., Holmes, T., Shearer, R., Wright, L. S., Svendsen, C. N., Gamm, D. M. and Lund, R. D. (2008), “Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration”, Investigative Ophtthalmology & Visual Science, Vol. 49 No. 7, pp. 3201-6.
Wiklander, O. P. B., Brennan, M. A., Lötvall, J., Breakefield, X. O. and Andaloussi, S. E. (2019), “Advances in therapeutic applications of extracellular vesicles”, Science Translational Medicine, Vol. 11 No. 492.
Copyright (c) 2024 Journal of Stem Cell Research and Tissue Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. As an author you (or your employer or institution) may do the following:
- make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use;
- make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g. via an e-mail list or list server);
- present the article at a meeting or conference and to distribute copies of the article to the delegates attending such meeting;
- for your employer, if the article is a ‘work for hire', made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g. training);
- retain patent and trademark rights and rights to any process, procedure, or article of manufacture described in the article;
- include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
- use the article or any part thereof in a printed compilation of your works, such as collected writings or lecture notes (subsequent to publication of the article in the journal); and prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full acknowledgement of its original publication in the journal;
- may reproduce or authorize others to reproduce the article, material extracted from the article, or derivative works for the author's personal use or for company use, provided that the source and the copyright notice are indicated, the copies are not used in any way that implies JSCRTE endorsement of a product or service of any employer, and the copies themselves are not offered for sale.
All copies, print or electronic, or other use of the paper or article must include the appropriate bibliographic citation for the article's publication in the journal.
2. Requests from third parties
Although authors are permitted to re-use all or portions of the article in other works, this does not include granting third-party requests for reprinting, republishing, or other types of re-use. Requests for all uses not included above, including the authorization of third parties to reproduce or otherwise use all or part of the article (including figures and tables), should be referred to JSCRTE by going to our website at http://e-journal.unair.ac.id/index.php/JSCRTE
3. Author Online Use
- Personal Servers. Authors and/or their employers shall have the right to post the accepted version of articles pre-print version of the article, or revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on their own personal servers or the servers of their institutions or employers without permission from JSCRTE, provided that the posted version includes a prominently displayed JSCRTE copyright notice and, when published, a full citation to the original publication, including a link to the article abstract in the journal homepage. Authors shall not post the final, published versions of their papers;
- Classroom or Internal Training Use. An author is expressly permitted to post any portion of the accepted version of his/her own articles on the author's personal web site or the servers of the author's institution or company in connection with the author's teaching, training, or work responsibilities, provided that the appropriate copyright, credit, and reuse notices appear prominently with the posted material. Examples of permitted uses are lecture materials, course packs, e-reserves, conference presentations, or in-house training courses;
- Electronic Preprints. Before submitting an article to an JSCRTE, authors frequently post their manuscripts to their own web site, their employer's site, or to another server that invites constructive comment from colleagues. Upon submission of an article to JSCRTE, an author is required to transfer copyright in the article to JSCRTE, and the author must update any previously posted version of the article with a prominently displayed JSCRTE copyright notice. Upon publication of an article by the JSCRTE, the author must replace any previously posted electronic versions of the article with either (1) the full citation to the work with a Digital Object Identifier (DOI) or link to the article abstract in JSCRTE homepage, or (2) the accepted version only (not the final, published version), including the JSCRTE copyright notice and full citation, with a link to the final, published article in journal homepage.
4. Articles in Press (AiP) service
JSCRTE may choose to publish an abstract or portions of the paper before we publish it in the journal. Please contact our Production department immediately if you do not want us to make any such prior publication for any reason, including disclosure of a patentable invention.
5. Author/Employer Rights
If you are employed and prepared the article on a subject within the scope of your employment, the copyright in the article belongs to your employer as a work-for-hire. In that case, JSCRTE assumes that when you sign this Form, you are authorized to do so by your employer and that your employer has consented to the transfer of copyright, to the representation and warranty of publication rights, and to all other terms and conditions of this Form. If such authorization and consent has not been given to you, an authorized representative of your employer should sign this Form as the Author.
6. JSCRTE Copyright Ownership
It is the formal policy of JSCRTE to own the copyrights to all copyrightable material in its technical publications and to the individual contributions contained therein, in order to protect the interests of the JSCRTE, its authors and their employers, and, at the same time, to facilitate the appropriate re-use of this material by others. JSCRTE distributes its technical publications throughout the world and does so by various means such as hard copy, microfiche, microfilm, and electronic media. It also abstracts and may translate its publications, and articles contained therein, for inclusion in various compendiums, collective works, databases and similar publications
Every accepted manuscript should be accompanied by "Copyright Transfer Agreement" prior to the article publication.
